Integrating oxaliplatin with highly luminescent carbon dots : an unprecedented theranostic agent for personalized medicine

© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 26(2014), 21 vom: 04. Juni, Seite 3554-60
1. Verfasser: Zheng, Min (VerfasserIn)
Weitere Verfasser: Liu, Shi, Li, Jing, Qu, Dan, Zhao, Haifeng, Guan, Xingang, Hu, Xiuli, Xie, Zhigang, Jing, Xiabin, Sun, Zaicheng
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Validation Study bioimaging bionanotechnology carbon nanoparticles oxaliplatin personalized medicine theranostics Antineoplastic Agents mehr... Carbon Compounds, Inorganic Organoplatinum Compounds Oxaliplatin 04ZR38536J
LEADER 01000naa a22002652 4500
001 NLM236442090
003 DE-627
005 20231224105558.0
007 cr uuu---uuuuu
008 231224s2014 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.201306192  |2 doi 
028 5 2 |a pubmed24n0788.xml 
035 |a (DE-627)NLM236442090 
035 |a (NLM)24634004 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Zheng, Min  |e verfasserin  |4 aut 
245 1 0 |a Integrating oxaliplatin with highly luminescent carbon dots  |b an unprecedented theranostic agent for personalized medicine 
264 1 |c 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 11.05.2015 
500 |a Date Revised 30.09.2020 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
520 |a A theranostic nanomedicine (CD-Oxa) is synthesized by means of the condensation reaction between the amino groups on the surface of fluorescent carbon dots (CDs) and the carboxyl group of the oxaliplatin derivative Oxa(IV)-COOH. CD-Oxa, which integrates the optical properties of CDs and the anticancer function of oxaliplatin, could be used for simultaneous drug delivery and fluorescent tracking 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a Validation Study 
650 4 |a bioimaging 
650 4 |a bionanotechnology 
650 4 |a carbon nanoparticles 
650 4 |a oxaliplatin 
650 4 |a personalized medicine 
650 4 |a theranostics 
650 7 |a Antineoplastic Agents  |2 NLM 
650 7 |a Carbon Compounds, Inorganic  |2 NLM 
650 7 |a Organoplatinum Compounds  |2 NLM 
650 7 |a Oxaliplatin  |2 NLM 
650 7 |a 04ZR38536J  |2 NLM 
700 1 |a Liu, Shi  |e verfasserin  |4 aut 
700 1 |a Li, Jing  |e verfasserin  |4 aut 
700 1 |a Qu, Dan  |e verfasserin  |4 aut 
700 1 |a Zhao, Haifeng  |e verfasserin  |4 aut 
700 1 |a Guan, Xingang  |e verfasserin  |4 aut 
700 1 |a Hu, Xiuli  |e verfasserin  |4 aut 
700 1 |a Xie, Zhigang  |e verfasserin  |4 aut 
700 1 |a Jing, Xiabin  |e verfasserin  |4 aut 
700 1 |a Sun, Zaicheng  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 26(2014), 21 vom: 04. Juni, Seite 3554-60  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:26  |g year:2014  |g number:21  |g day:04  |g month:06  |g pages:3554-60 
856 4 0 |u http://dx.doi.org/10.1002/adma.201306192  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 26  |j 2014  |e 21  |b 04  |c 06  |h 3554-60